Consensus statement on novel glucose-related metrics obtained through advanced medical devices: English version

This publication has 70 references indexed in Scilit:

• Exploring time in tight range targets (TITR) in drug-naive Japanese individuals with type 2 diabetes
  Acta Diabetologica, 2024
• Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
  JAMA, 2021
• Positioning time in range in diabetes management
  Diabetologia, 2019
• Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
  JAMA, 2017
• Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
  Diabetes Therapy, 2016
• Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
  Diabetologia, 2016
• Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
  JAMA, 2016
• Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin
  Diabetologia, 2004
• Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up
  Diabetologia, 1996
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
  Diabetes Research and Clinical Practice, 1995